Elaiapharm – FDA Inspection, Jan 30, 2026

Record Details

This FDA Inspection record concerns Elaiapharm, with an inspection on January 30, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Elaiapharm
Inspection Date: January 30, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Khoa Nathan V. Tran (Company Rep)

View Company Profile

ID · f41b7279-c5b6-4a22-96e0-a515db881532

Inspection Facts

Inspection number: 1301450
FDA center: Human Drugs
Project area: New Drug Evaluation
Outcome: Form 483 issued

FDA Citations

21 CFR 211.192Investigations of discrepancies, failures
21 CFR 211.194(a)(4)Complete Test Data
21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Elaiapharm

FDA Inspection

ElaiapharmJanuary 30, 2026